Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.5M Buy
143,600
+111,200
+343% +$39.6M 0.01% 1575
2025
Q4
$10.6M Sell
32,400
-7,000
-18% -$2.22M ﹤0.01% 3041
2025
Q3
$11.1M Buy
39,400
+13,300
+51% +$3.86M ﹤0.01% 2860
2025
Q2
$7.29M Sell
26,100
-7,500
-22% -$2.12M ﹤0.01% 3062
2025
Q1
$10.5M Sell
33,600
-17,700
-35% -$5.23M ﹤0.01% 2653
2024
Q4
$13.4M Buy
51,300
+34,000
+197% +$10.1M ﹤0.01% 2517
2024
Q3
$5.57M Sell
17,300
-4,000
-19% -$1.31M ﹤0.01% 3247
2024
Q2
$6.66M Sell
21,300
-23,800
-53% -$6.99M ﹤0.01% 2892
2024
Q1
$12.8M Buy
45,100
+4,500
+11% +$1.32M ﹤0.01% 2252
2023
Q4
$11.7M Buy
40,600
+15,300
+60% +$4.17M ﹤0.01% 2387
2023
Q3
$6.8M Buy
25,300
+19,400
+329% +$4.84M ﹤0.01% 2726
2023
Q2
$1.31M Sell
5,900
-27,200
-82% -$6.31M ﹤0.01% 4163
2023
Q1
$8M Sell
33,100
-13,700
-29% -$3.36M ﹤0.01% 2630
2022
Q4
$12.3M Sell
46,800
-1,289,700
-96% -$346M ﹤0.01% 2402
2022
Q3
$301M Buy
1,336,500
+492,500
+58% +$119M 0.08% 248
2022
Q2
$205M Buy
844,000
+752,800
+825% +$184M 0.05% 387
2022
Q1
$22.1M Buy
91,200
+6,900
+8% +$1.59M ﹤0.01% 1974
2021
Q4
$19M Buy
84,300
+9,200
+12% +$1.94M ﹤0.01% 2152
2021
Q3
$16M Buy
75,100
+29,400
+64% +$6.77M ﹤0.01% 2279
2021
Q2
$11.1M Sell
45,700
-51,100
-53% -$12.6M ﹤0.01% 2589
2021
Q1
$24.1M Sell
96,800
-19,400
-17% -$4.63M 0.01% 1791
2020
Q4
$26.7M Sell
116,200
-53,000
-31% -$12.2M 0.01% 1619
2020
Q3
$43M Buy
169,200
+57,400
+51% +$14.2M 0.01% 1117
2020
Q2
$26.4M Sell
111,800
-85,100
-43% -$19.4M 0.01% 1452
2020
Q1
$39.9M Sell
196,900
-45,100
-19% -$9.85M 0.01% 1023
2019
Q4
$58.3M Sell
242,000
-150,700
-38% -$33.2M 0.01% 1031
2019
Q3
$76M Buy
392,700
+6,300
+2% +$1.21M 0.02% 826
2019
Q2
$71.2M Buy
386,400
+172,700
+81% +$30.9M 0.02% 903
2019
Q1
$40.6M Buy
213,700
+69,800
+49% +$13.3M 0.01% 1300
2018
Q4
$28M Buy
143,900
+69,900
+94% +$13.6M 0.01% 1536
2018
Q3
$15.3M Sell
74,000
-51,400
-41% -$10.1M ﹤0.01% 2118
2018
Q2
$23.1M Sell
125,400
-39,500
-24% -$6.99M 0.01% 1767
2018
Q1
$28.1M Sell
164,900
-98,300
-37% -$18M 0.01% 1568
2017
Q4
$45.8M Buy
263,200
+25,100
+11% +$4.44M 0.01% 1352
2017
Q3
$44.4M Buy
238,100
+28,800
+14% +$5.1M 0.01% 1375
2017
Q2
$36M Sell
209,300
-218,200
-51% -$35.5M 0.01% 1484
2017
Q1
$70.1M Sell
427,500
-153,200
-26% -$25.5M 0.02% 995
2016
Q4
$84.9M Sell
580,700
-106,500
-15% -$16M 0.02% 890
2016
Q3
$115M Sell
687,200
-49,200
-7% -$8.32M 0.03% 638
2016
Q2
$112M Buy
736,400
+365,600
+99% +$56.8M 0.04% 598
2016
Q1
$55.6M Sell
370,800
-26,500
-7% -$3.94M 0.02% 1015
2015
Q4
$64.5M Sell
397,300
-157,600
-28% -$24.8M 0.02% 942
2015
Q3
$76.8M Buy
554,900
+334,900
+152% +$52.8M 0.03% 772
2015
Q2
$33.8M Buy
220,000
+24,500
+13% +$3.92M 0.01% 1409
2015
Q1
$31.3M Buy
195,500
+19,000
+11% +$2.99M 0.01% 1445
2014
Q4
$28.1M Buy
176,500
+27,800
+19% +$4.33M 0.01% 1569
2014
Q3
$20.9M Sell
148,700
-72,200
-33% -$9.43M 0.01% 1762
2014
Q2
$26.1M Sell
220,900
-59,200
-21% -$6.85M 0.01% 1586
2014
Q1
$34.5M Sell
280,100
-273,400
-49% -$33.2M 0.01% 1320
2013
Q4
$63.1M Sell
553,500
-131,000
-19% -$14.9M 0.02% 902
2013
Q3
$76.6M Buy
684,500
+179,800
+36% +$19.5M 0.03% 708
2013
Q2
$49.8M Buy
+504,700
New +$52.4M 0.02% 910

Other funds holding AMGN

Goldman Sachs's AMGN Position: Q1 2026 in Review

Goldman Sachs reduced its Amgen (AMGN) stake by 6.8% in Q1 2026, selling an estimated $111M and leaving 4,219,989 shares worth $1.48B. The position accounts for 0.17% of the portfolio, ranked #97.

Goldman Sachs first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.01B in Q3 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Goldman Sachs held 4,219,989 shares of Amgen worth $1.48B as of Q1 2026.
  • Goldman Sachs sold 310,269 Amgen shares in Q1 2026, an estimated $111M.
  • Amgen made up 0.17% of Goldman Sachs's portfolio in Q1 2026, its #97 holding.
  • Goldman Sachs first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Amgen position peaked at $2.01B in Q3 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.